Skip to main content
Premium Trial:

Request an Annual Quote

Serologicals to Acquire Upstate for $205 Million

NEW YORK, Sep. 8 (GenomeWeb News) - Serologicals has entered into a definitive agreement to acquire Upstate Group for a combination of cash and stock worth $205 million.

 

Atlanta-based Serologicals said that it will issue up to 5 million shares its common stock, which currently trades at $21.20 on the NASDAQ, and the balance of the price will be paid in cash.

 

Privately held Upstate employs 260 people worldwide and recorded revenues of $44.4 million for fiscal year 2003. The firm is based in Charlottesville, Va., and has manufacturing facilities in Lake Placid, N.Y. and Dundee, Scotland.

 

Upstate sells cell signaling research reagents to academic, biotech and pharmaceutical investigators. Serologicals expects the deal will provide the company with a significant presence in the preclinical drug screening and target validation market, with a focus on kinase screening and protein interaction. The firm also said that it expects the Upstate and Chemicon subsidiaries would launch approximately 1,500 new research products per year.

 

Serologicals, which anticipates closing the acquisition in the fourth quarter of this year, said the deal will add roughly $80 million to its revenues and between $.03 and $.05 to its diluted earnings per share in fiscal 2005. The acquisition was approved by Serologicals' board of directors and by holders of approximately 90 percent of the shares of voting stock of Upstate.

 

JPMorgan Chase Bank will finance the cash portion of the purchase under a new credit facility for Serologicals. JPMorgan also acted as exclusive financial advisor to Serologicals on the transaction.

 

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.